EDN1 and colorectal carcinoma: To explore the correlation between EDN1 expression and oxaliplatin sensitivity, we quantified oxaliplatin IC50 values (Fig. 2C) and EDN1 mRNA levels (Fig. 2D) across seven CRC cell lines.